India's biggest drugmaker Sun Pharmaceutical Industries on Thursday posted a 117% year-on-year rise in the net profit for the quarter ended September. The firm's net profit rose to  ₹2,235 crore compared to ₹1,029 crore in the corresponding period last year. Reportedly, sales in the United States, India and in other emerging markets rose considerably.